Cargando…

A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II

In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment sessi...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutsomitros, Theodoros, van der Zee, Kenneth T., Evagorou, Olympia, Schuhmann, Teresa, Zamar, Antonis C., Sack, Alexander T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505040/
https://www.ncbi.nlm.nih.gov/pubmed/36143081
http://dx.doi.org/10.3390/jcm11185434
_version_ 1784796373176025088
author Koutsomitros, Theodoros
van der Zee, Kenneth T.
Evagorou, Olympia
Schuhmann, Teresa
Zamar, Antonis C.
Sack, Alexander T.
author_facet Koutsomitros, Theodoros
van der Zee, Kenneth T.
Evagorou, Olympia
Schuhmann, Teresa
Zamar, Antonis C.
Sack, Alexander T.
author_sort Koutsomitros, Theodoros
collection PubMed
description In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment session of 1000 pulses for 20 consecutive working days, accumulating to 20.000 rTMS pulses applied over 4 weeks. We measured the patients’ symptoms before the start, halfway through, directly after, and one month after treatment. We quantified the depression symptoms using both the Beck depression inventory scale and the symptom checklist-90 depression subscale. Patients showed a significant reduction in depression symptoms directly after treatment and an even further reduction one month after treatment. The remission rates were at 26% halfway through treatment (after the 10th session), 61% directly after treatment (after the 20th session), and increased to 78% at the 1-month follow-up. Importantly, the protocol proved to be feasible and highly tolerable in this patient population, with no adverse effects being reported. Considering these positive results, further research should focus on replicating these findings in larger clinical samples with control groups and longer follow-up periods, while potentially adding maintenance sessions to optimize the treatment effect and stability for bipolar disorder type II patients.
format Online
Article
Text
id pubmed-9505040
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95050402022-09-24 A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II Koutsomitros, Theodoros van der Zee, Kenneth T. Evagorou, Olympia Schuhmann, Teresa Zamar, Antonis C. Sack, Alexander T. J Clin Med Article In this open-label naturalistic study, we assess the feasibility, tolerability, and effectiveness of a repetitive transcranial magnetic stimulation protocol with a reduced total pulse number for treating patients suffering from bipolar disorder type II. All patients received one rTMS treatment session of 1000 pulses for 20 consecutive working days, accumulating to 20.000 rTMS pulses applied over 4 weeks. We measured the patients’ symptoms before the start, halfway through, directly after, and one month after treatment. We quantified the depression symptoms using both the Beck depression inventory scale and the symptom checklist-90 depression subscale. Patients showed a significant reduction in depression symptoms directly after treatment and an even further reduction one month after treatment. The remission rates were at 26% halfway through treatment (after the 10th session), 61% directly after treatment (after the 20th session), and increased to 78% at the 1-month follow-up. Importantly, the protocol proved to be feasible and highly tolerable in this patient population, with no adverse effects being reported. Considering these positive results, further research should focus on replicating these findings in larger clinical samples with control groups and longer follow-up periods, while potentially adding maintenance sessions to optimize the treatment effect and stability for bipolar disorder type II patients. MDPI 2022-09-16 /pmc/articles/PMC9505040/ /pubmed/36143081 http://dx.doi.org/10.3390/jcm11185434 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Koutsomitros, Theodoros
van der Zee, Kenneth T.
Evagorou, Olympia
Schuhmann, Teresa
Zamar, Antonis C.
Sack, Alexander T.
A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title_full A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title_fullStr A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title_full_unstemmed A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title_short A Different rTMS Protocol for a Different Type of Depression: 20.000 rTMS Pulses for the Treatment of Bipolar Depression Type II
title_sort different rtms protocol for a different type of depression: 20.000 rtms pulses for the treatment of bipolar depression type ii
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505040/
https://www.ncbi.nlm.nih.gov/pubmed/36143081
http://dx.doi.org/10.3390/jcm11185434
work_keys_str_mv AT koutsomitrostheodoros adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT vanderzeekennetht adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT evagorouolympia adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT schuhmannteresa adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT zamarantonisc adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT sackalexandert adifferentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT koutsomitrostheodoros differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT vanderzeekennetht differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT evagorouolympia differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT schuhmannteresa differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT zamarantonisc differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii
AT sackalexandert differentrtmsprotocolforadifferenttypeofdepression20000rtmspulsesforthetreatmentofbipolardepressiontypeii